F. S. Mennini, M. Paoletti, C. Bini, A. Marcellusi, M. Falcone, and M. Andreoni, “Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP)”, Grhta, vol. 9, no. 1, pp. 45–57, Apr. 2022.